Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Semaglutide – a game-changer in obesity management

Written by | 9 May 2023

Alex Miras is Professor of Endocrinology at the University of Ulster, UK and is an expert in obesity management and research. In 2021 a trial of semaglutide for… read more.

Diabetes drug shows promise for “blinding headache” condition

Written by | 23 Apr 2023

Exenatide, an injectable treatment for type 2 diabetes, has shown efficacy for the treatment of ‘blinding’ headaches known as idiopathic intercranial hypertension (IIH). Researchers from a phase 2… read more.

Use age, not weight, to screen for diabetes

Written by | 26 Mar 2023

Focus on age, not weight, to capture the greatest number of people in all racial and ethnic groups with prediabetes and diabetes, reports a new Northwestern Medicine study…. read more.

Vitamin D supplementation may lower diabetes risk for the more than 10 million adults with prediabetes

Written by | 10 Feb 2023

A review of clinical trials has found that higher vitamin D intake was associated with a 15 percent decreased likelihood for developing type 2 diabetes in adults with… read more.

UK study shows increased cancer mortality in people with type 2 diabetes

Written by | 29 Jan 2023

New research, funded by Hope Against Cancer and published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) shows that cancer mortality in people with… read more.

Another step toward an insulin tablet

Written by | 15 Jan 2023

For the millions of people living with diabetes, insulin is a life-saving drug. Unlike many other medicines, though, insulin cannot be easily delivered by swallowing a pill —… read more.

Gut bacteria may play a role in diabetes

Written by | 6 Jan 2023

One type of bacteria found in the gut may contribute to the development of Type 2 diabetes, while another may protect from the disease, according to early results… read more.

Metformin reduces risk of joint replacement in diabetes patients

Written by | 19 Dec 2022

Metformin use appears to lower the risk of total joint replacement in patients with type 2 diabetes. Researchers reported this finding on December 19, 2022 in the CMAJ/Canadian… read more.

SGLT2 treatment improves outcomes in patients without diabetes

Written by | 13 Dec 2022

Researchers from a new meta-analysis of data report that, in addition to its known benefits, sodium glucose co-transporter-2 inhibitor (SGLT2) treatment reduces the risk of adverse kidney and… read more.

Findings support repurposing rheumatoid arthritis drug auranofin for diabetes

Written by | 20 Oct 2022

Researchers at Baylor College of Medicine and collaborating institutions discovered that the rheumatoid arthritis drug auranofin can potentially be repurposed to improve diabetes-associated symptoms. The study, which was… read more.

Women with diabetes at an early age likely to enter menopause early

Written by | 16 Oct 2022

Persons living with diabetes are at greater risk of a number of health conditions including eye and foot problems, heart attacks and strokes, and kidney and nerve damage…. read more.

Team developing oral insulin tablet sees breakthrough results

Written by | 3 Sep 2022

A team of University of British Columbia researchers working on developing oral insulin tablets as a replacement for daily insulin injections have made a game-changing discovery. Researchers have… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.